Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Micoli

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Frontiers in Cellular and Infection Microbiology|February 21, 2022
Dissecting <i>in Vitro</i> the Activation of Human Immune Response Induced by <i>Shigella sonnei</i> GMMASerena Tondi, Bruna Clemente, Carmen Esposito, et al.
Plos One|July 26, 2017
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1Arianna Marini, Omar Rossi, Maria Grazia Aruta, et al.
NPJ Vaccines|April 15, 2025
GMMA decorated with mucin 1 Tn/STn mimetics elicit specific antibodies response and inhibit tumor growthElisa Pesce, Andrea Sodini, Elena Palmieri, et al.
Pathogens (Basel, Switzerland)|July 2, 2021
<i>Neisseria meningitidis</i> Factor H Binding Protein Surface Exposure on <i>Salmonella</i> Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both DiseasesFrancesca Necchi, Giuseppe Stefanetti, Renzo Alfini, et al.
Frontiers in Immunology|May 21, 2021
Antibodies Elicited by the <i>Shigella sonnei</i> GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster ExtensionFrancesca Micoli, Omar Rossi, Valentino Conti, et al.
Frontiers in Immunology|May 8, 2026
Preclinical evaluation of multivalent vaccine combinations against <i>Shigella</i> and <i>Salmonella</i> infectionsRoberta Di Benedetto, Rebecca Nappini, Salvatore Gemmellaro, et al.
Frontiers in Immunology|October 1, 2021
Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal ModelsFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Vaccines|September 22, 2020
GMMA Is a Versatile Platform to Design Effective Multivalent Combination VaccinesFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Vaccines|April 3, 2021
Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine PotencyElena Palmieri, Vanessa Arato, Davide Oldrini, et al.
Frontiers in Immunology|October 7, 2022
Complement-mediated serum bactericidal activity of antibodies elicited by the <i>Shigella sonnei</i> GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized studyMelissa C Kapulu, Usman Nakakana, Antonella S Sciré, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Cellular and Infection Microbiology|February 21, 2022
Dissecting <i>in Vitro</i> the Activation of Human Immune Response Induced by <i>Shigella sonnei</i> GMMASerena Tondi, Bruna Clemente, Carmen Esposito, et al.
Plos One|July 26, 2017
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1Arianna Marini, Omar Rossi, Maria Grazia Aruta, et al.
NPJ Vaccines|April 15, 2025
GMMA decorated with mucin 1 Tn/STn mimetics elicit specific antibodies response and inhibit tumor growthElisa Pesce, Andrea Sodini, Elena Palmieri, et al.
Pathogens (Basel, Switzerland)|July 2, 2021
<i>Neisseria meningitidis</i> Factor H Binding Protein Surface Exposure on <i>Salmonella</i> Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both DiseasesFrancesca Necchi, Giuseppe Stefanetti, Renzo Alfini, et al.
Frontiers in Immunology|May 21, 2021
Antibodies Elicited by the <i>Shigella sonnei</i> GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster ExtensionFrancesca Micoli, Omar Rossi, Valentino Conti, et al.
Frontiers in Immunology|May 8, 2026
Preclinical evaluation of multivalent vaccine combinations against <i>Shigella</i> and <i>Salmonella</i> infectionsRoberta Di Benedetto, Rebecca Nappini, Salvatore Gemmellaro, et al.
Frontiers in Immunology|October 1, 2021
Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal ModelsFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Vaccines|September 22, 2020
GMMA Is a Versatile Platform to Design Effective Multivalent Combination VaccinesFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Vaccines|April 3, 2021
Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine PotencyElena Palmieri, Vanessa Arato, Davide Oldrini, et al.
Frontiers in Immunology|October 7, 2022
Complement-mediated serum bactericidal activity of antibodies elicited by the <i>Shigella sonnei</i> GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized studyMelissa C Kapulu, Usman Nakakana, Antonella S Sciré, et al.
Pageof 13